pargyline has been researched along with Hyperthyroid in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| " neonatal hyperthyroidism, produced by daily administration of L-triiodothyronine from birth, had no effect on the ontogenic patterns of serotonin." | 3.65 | Thyroid hormone control of serotonin in developing rat brain. ( Keesey, RR; Schwark, WS, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwark, WS | 1 |
| Keesey, RR | 1 |
| Callingham, BA | 1 |
| Lyles, GA | 1 |
2 other studies available for pargyline and Hyperthyroid
| Article | Year |
|---|---|
Thyroid hormone control of serotonin in developing rat brain.
Topics: Animals; Animals, Newborn; Basal Ganglia; Brain; Brain Stem; Congenital Hypothyroidism; Hyperthyroid | 1975 |
Proceedings: An effect of thyroid hormones upon monoamine oxidase activity.
Topics: Aging; Animals; Half-Life; Hyperthyroidism; Hypothyroidism; Male; Monoamine Oxidase; Myocardium; Org | 1974 |